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Abstract: Semi-synthetic, proteolytically degradable poly-
mer hydrogels have proven effective as scaffolds to aug-
ment bone and skin regeneration in animals. However,
high costs due to expensive peptide building blocks pose a
signiﬁcant hurdle towards broad clinical usage of these
materials. Here we demonstrate that tri-amino acid pep-
tides bearing lysine (or arginine), ﬂanked by two cysteine
residues for crosslinking, are adequate as minimal plas-
min-sensitive peptides in poly(ethylene glycol)-based
hydrogels formed via Michael-type addition. Substitution
of lysine (or arginine) with serine rendered the matrices
insensitive to the action of plasmin. This was demon-
strated in vitro by performing gel degradation experiments
in the presence of plasmin (0.1 U/mL), and in the in vivo
situation of regeneration of critical-sized bone defects.
When placed as implants into rat calvaria, gels formed
from the minimal plasmin substrates showed clear signs of
cell inﬁltration and gel remodeling that coincided with
extensive bone formation.  2009 Wiley Periodicals, Inc.
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INTRODUCTION
Tissue regeneration typically starts with the
formation of a ﬁbrin hydrogel, polymerized in a
wound immediately after injury to stop bleeding,
which serves as temporary cellular scaffold for cell
inﬁltration into the wound from the surrounding
tissue.1,2 The ﬁbrin matrix is subsequently degraded
and replaced by a newly formed tissue-speciﬁc
extracellular matrix network. Cell-secreted and -acti-
vated proteases such as matrix metalloproteases
(MMPs) and the serine protease plasmin are the
key effectors in this localized ﬁbrin breakdown.
They enable inﬂammatory and tissue-speciﬁc
cells to populate the clot and to initiate ﬁbrin
remodeling.3
Emerging biomaterials approaches to tissue regen-
eration have focused on mimicking ﬁbrin to form
biomaterials in situ, at the site of a tissue defect, act-
ing as degradable scaffolds to stimulate the regener-
ation process.4,5 The complexity and wide range of
targeted clinical applications for such biomaterials
necessitates ﬂexible design strategies. The scaffold
should have biological and physico–chemical charac-
teristics that are tunable toward speciﬁc medical
needs and particular tissues. Engineered biomaterials
should overcome some of the limitations of ‘‘clas-
sical,’’ state-of-the-art regeneration matrices such as
collagen or ﬁbrin itself. Although these biopolymer
networks possess outstanding biological characteris-
tics, their inherent properties such as degradation
kinetics are difﬁcult to adapt to speciﬁc applications.
Some of us had previously engineered key bio-
chemical characteristics of naturally derived matrices
into synthetic, poly(ethylene glycol) (PEG) hydrogel
networks.6–12 Accordingly, hydrogels equipped with
peptides to facilitate cell adhesion and susceptibility
to degradation by either MMPs,8–10,13,14 plasmin7,11
or to both proteases,12 enable proteolytic cell migra-
tion in 3-dimensions, a rather complex physiological
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process. Moreover, in the presence of potent tissue-
inducing biomolecules such as bone morphogenetic
protein-2 (BMP-2)8,10–12 or vascular endothelial
growth factor,5,9,15 these hydrogels stimulated exten-
sive bone regeneration and angiogenesis, respec-
tively. The earlier studies also underscored the im-
portance of designing matrix proteolytic sensitivity,
as in the absence of this functionality the lack of cell
inﬁltration and matrix remodeling led to signiﬁ-
cantly reduced tissue regeneration.
Although synthetic biomimetic hydrogels can per-
form surprisingly well in a biological environment,
augmenting bone regeneration or stimulating angio-
genesis, they suffer from relatively high production
costs when compared with biologically derived
scaffolds. Oligopeptide gel components represent the
main cost factor for this class of materials, with costs
increasing nearly proportional to the peptide length.
The high costs can present a limitation to wide-range
clinical application.
To reduce the peptide length and, thus, the costs of
synthetic biomimetic hydrogels, the main goal of this
study was to explore materials designs with minimal
length of the proteolytically-sensitive linker peptide.
We focused on plasmin-degradable peptides due to
the relevance of plasmin in proteolytic remodeling of
ﬁbrin1 and our previous ﬁndings with relatively short
plasmin substrates as hydrogel components.11 We
found that hydrogels formed with the tri-amino acid
peptides bearing either lysine or arginine, but not ser-
ine residues, are susceptible to plasmin degradation
both in vitro and in vivo.
EXPERIMENTAL
Materials
Ac-CKC-NH2 (CKC, Mw: 394 Da, net peptide content:
70.6%), Ac-CRC-NH2 (CRC, Mw: 422 Da, net peptide
content: 73.8%), and Ac-CSC-NH2 (CSC, Mw: 353 Da, net
peptide content was not provided and was assumed to be
100%) were purchased from Neosystems (Strasbourg,
France). These peptides were designed containing single
amino acids ﬂanked only by cysteines to allow the
peptides to undergo crosslinking with branched, vinylsul-
fone (VS)-terminated PEGs to form hydrogels via Michael-
type addition. Peptide purity was 95–96% as determined
by HPLC analysis. Peptide Ac-GCYK;NR;DCG-NH2
(C2KR, Mw: 1056 Da; ; marks cleavage sites) was synthe-
sized and puriﬁed as reported earlier.11 A 4-arm PEG-OH
(Mw: 20 kDa) was purchased from Nektar (Huntsville) and
functionalized with VS groups PEG (4-arm PEG-VS) as
described earlier.16,17 The degree of end-group conversion
assessed by 1H NMR (400.13 MHz, CDCl3) was shown
to be 81%: d 6.87–6.78 (dd, CH¼CH2), 6.43–6.36
(d, CH¼CH2), 6.10–6.06 (d, CH¼CH2), and 3.69–3.61
(s, CH2CH2O).
Rheometry and equilibrium swelling (Qm)
Rheological experiments were performed with a Bohlin
CVO 120 high-resolution rheometer with plate-plate
geometry at 258C as described previously.16 Qm was
deﬁned as the ratio of the mass of swollen gel to the mass
of dried gel.
Hydrogel formation
Hydrogels were formed at 20% (w/v) via Michael-type
conjugate addition of peptide thiols (Schemes 1 and 2)
onto VS of end-functionalized 4-arm PEG-VS in 0.3M of
triethanolamine (TEOA) buffer at pH 7.6, using previously
published methods.16,17 Brieﬂy, to form 25 lL hydrogels
containing 20% (w/v) polymer, precursor solutions were
mixed at various stoichiometric ratios r 5 [SH]/[VS] (SH,
cysteine thiols; VS groups on PEG termini) and formed as
disks between two Sigma-coated (Sigamacote1, Sigma-
Aldrich, Germany) glass slides separated by 0.8-mm thick
spacers. Crosslinking was allowed to proceed for 30 min at
378C in a humidiﬁed atmosphere, and the gels were
swollen overnight in 0.1M phosphate buffered saline (PBS)
(pH 7.4).
Hydrogel degradation
Hydrogel disks (25 lL) were incubated in a solution of
4-mL PBS containing 0.1-U/mL bovine plasmin (Roche,
Switzerland). Samples were weighted at different time
points. Each condition was measured in triplicate.
Preparation of hydrogel disks for
animal experiments
To facilitate cell invasion into nonadhesive hydrogels,
gel formulations described earlier (see Hydrogel forma-
tion) were augmented to covalently attach the integrin-
binding peptide Ac-GCGYGRGDSPG-NH2 to the gel
network following published protocols.10 Moreover, 5 lg
rhBMP-2 was physically entrapped into gels by mixing it
with the PEG precursor before gelation, according to
published methods.10
Animal experimentation
Animal experiments were authorized by the Veterinary
Authority of the Canton of Zurich. Adult female Sprague-
Dawley albino rats (300–350 g) were used and bone regen-
eration experiments were conducted exactly according to
published methods.10,11 Explants were sequentially dried,
defatted, ﬁxed, and embedded. Sections were stained with
Toluidine blue O and Goldner Trichrome. Three animals
were used per gel type.
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RESULTS AND DISCUSSION
Design of minimal putative plasmin
substrate peptides
West and Hubbell had previously synthesized PEG-
based gels from telechelic macromers modiﬁed by the
plasmin-sensitive oligopeptide Val-Arg-Asn (VR;N,
; denotes proteolytic cleavage site), derived from the
a-chain of ﬁbrinogen. This peptide was found to be
cleavable by plasmin proteolysis, yet insensitive to the
action of other proteolytic enzymes, such as MMPs or
elastase.6 In later generations of PEG-based plasmin-
sensitive hydrogels, some of us used either single or
multiple ﬁbrinogen-derived plasmin substrates within
a given peptide, Ac-GCYK;NR;DCGYK;NR;CG-
NH2,
11 or recombinant protein polymer, -(. . .NNR;
DNTYNR;VSEDL. . .)n-,
7 -(. . .NNR;DNTY. . .)n-
17 Inter-
estingly, in the latter study, biochemical investigations
revealed the presence of unexpected plasmin cleavage
sites in negative control constructs and N-terminal
sequencing of plasmin-degraded products indicated
that the C-terminus of arginine residues in the proteins
might act as substrates for plasmin.17 Indeed, arginines
and lysines typically mark cleavage sites in proteins18
and are commonly known P1 sites (i.e., amino acids
adjacent to the C-terminus of the proteolytic cleavage
site). Oftentimes, arginine cleavage sites are ﬂanked by
amino acids with aromatic side groups such as tyrosine
or tryptophan.19,20 Based on these ﬁndings, we
hypothesized that isolated lysine or arginine residues
might be sufﬁcient to act as substrates for plasmin in
PEG-based hydrogels. To test this hypothesis, we
designed peptides containing single amino acids
ﬂanked only by cysteines (cysteine-lysine-cysteine, CKC,
and cysteine-arginine-cysteine, CRC, see Scheme 1).
This peptide design allowed the peptides to undergo
crosslinking with branched, VS-terminated PEGs to
form hydrogels via Michael-type addition (Scheme 2).
As potential negative control peptide, the amino acid
serine was ﬂanked by cysteines.
Hydrogel formation and characterization
We next tried to form solid hydrogels via Michael-
type addition (Scheme 2) by mixing two liquid pre-
cursors containing 4-arm PEG-VS and each of the
above Cys-containing tri-amino acid peptides
(Scheme 1). Indeed, at pH 7.6, we were able to form
hydrogels within about 10 min after mixing of rela-
tively highly concentrated aqueous precursors.
Remarkably, when compared with our previous
PEG-co-peptide gel system,16 in which networks
were formed at precursor concentrations as low as
5% (note: same PEG macromers were used but 16-
Scheme 1. Designed tri-amino acid peptides (top). The plasmin-sensitive peptide C2KR (bottom) was selected as a posi-
tive control based on earlier work.11
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amino acid-long peptides), gel crosslinked with very
small peptides only formed reliably at concentrations
above 15%. To determine the ratio of functional
groups that would lead to nearly ideal gel net-
works,16,17 the equilibrium swelling ratio Qm and
elastic modulus G0 of swollen gels were determined
as a function of r 5 [SH]/[VS] (Figs. 1 and 2). A
minimal Qm and maximum in G
0 at ropt was found
at slightly excessive amounts of SH-groups for CKC
(ropt 5 1.1) and CRC (1.15), respectively, and r 5 0.9
for CSC.
The slight excess of thiols that was required to
obtain optimal physico–chemical properties in CKC
and CRC gels can most likely be attributed to the
SH-consumption via disulﬁde bond (SS) for-
mation, that may occur concurrently with the
Michael-type addition.16,17 The rather unexpected
ropt of hydrogels crosslinked with CSC (r < 1) may
be explained by a different reactivity of thiols to
form either covalent bonds with VS or disulﬁde
bonds due to differences in thiol pKa’s.21 This is to
say, we had previously demonstrated that the pKa
of the sulfhydryl groups of cysteines is highly
dependent on adjacent charged amino acids, posi-
tively charged amino acids lowering the pKa, and
negatively charged amino acids having the opposite
effect. Because deprotonated thiols are the reactive
species in the conjugate addition reaction, lysine
and arginine render thiols in CKC and CRC more
reactive than serine in CSC.
Hydrogel degradation characteristics
To investigate the proteolytic degradation kinetics
upon exposure to plasmin, hydrogels with different
linker types but equivalent swelling ratios and elas-
tic moduli (r 5 0.85 for CSC, 1.1 for CKC, and 1.15
for CRC, respectively) were selected, and swelling
and weight loss determined as a function of incuba-
tion time (Fig. 3). As expected, gels containing the
plasmin-sensitive control peptides C2KR showed the
fastest degradation, primarily mediated by surface
erosion (i.e., no increase in gel weight during disso-
lution). Complete gel dissolution occurred after
about 5 h of incubation, consistent with previous
ﬁndings11 [Fig. 3(a)]. In marked contrast, no weight
change and thus degradation was observed during
the 6-day test period in gels containing the control
peptide CSC.
CKC- and CRC-containing hydrogels exhibited sen-
sitivity to plasmin degradation [Fig. 3(a,b)]. CKC-bear-
ing gels degraded signiﬁcantly faster than those cross-
linked with CRC (ca. 130 h vs. ca. 240 h for complete
gel dissolution, respectively). We also noted that CKC-
and CRC-gels initially increased in weight during deg-
radation, suggesting a predominant bulk degradation
mechanism, in contrast to C2KR-containing control
gels that appeared to primarily degrade via surface
erosion. Notably, the peptide VRN (Val-Arg-Asn) that
was introduced in earlier work as plasmin-sensitive
substrate within photopolymerized PEG-based hydro-
gels showed slower degradation kinetics (400 h at
2 U/mL plasmin; 600 h at 0.2 U/mL)6 when compared
with gels made with CKC-peptide (130 h at 0.1 U/mL
plasmin). Therefore, these results clearly demonstrate
that arginine or lysine alone, when ﬂanked by reactive
cysteines, can serve as effective plasmin substrates in
crosslinked PEG-based hydrogels. However, it should
also be noted that other proteolytic enzymes, such as
MMPs, may cleave these peptides.
Proteolytic enzymes usually bind to substrates
comprised of several amino acids. Various methodol-
ogies, ranging from classical amino acid sequence
studies22 to positional scanning libraries of ﬂuoro-
Scheme 2. PEG-co-peptide hydrogel formation by Michael-type addition.
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genic peptides19 and microarray techniques20 have
been used to uncover the primary peptide structure
of ﬁbrinogen plasmin substrates. Speciﬁcity is pri-
marily determined by the amino acid in P1 position.
In some substrates, the P1 residue and the following
P10 amino acid will contribute to interactions that
deﬁne the cleavage site.23 It is widely accepted that
substrates with lysine at P1 are degraded faster than
with arginine in that position,19,20,24 which is in
agreement with our results. From structural analyses
of the human ﬁbrinogen a-chain, several amino
acids including methionine, serine, or alanine were
identiﬁed as P10 sites,22 though it is still poorly
understood which P10 amino acid induces the fastest
degradation.25 Moreover, the active site of plasmin
ﬁts best in a substrate ‘‘pocket’’ that contains tyrosine
or tryptophan at P2.19 The C2KR peptide ﬁts these
criteria and shows signiﬁcantly faster degradation
when compared with CKC or CRC. To the best of
our knowledge, polymer-conjugated cysteines were
not previously reported as P10 and P2 sites. Our
results show that cysteines with their thiols bound
to VSs via thioether bonds can act as P10 and P2 site,
as plasmin degradability of gels bearing Cys-contain-
ing tri-amino acid peptide is retained.
In vivo enzymatic degradation: Induction
of bone regeneration
To test the susceptibility to degradation of the
newly designed plasmin-sensitive gels in a relevant
in vivo scenario, we utilized the previously estab-
lished rat calvarial bone defect model.26 This model
is frequently used to test the suitability of bioactive
molecules, such as BMP, and scaffolds to induce
regeneration of large bone defects and our group
had used it successfully in the development of plas-
min-sensitive gels.11 We fabricated gel disks (8 mm
diameter) containing noncovalently entrapped BMP-
2, implanted the samples in critical size defects of
Figure 1. Equilibrium swelling (Qm) of hydrogels formed
from 4-arm PEG-VS and tri-amino acid linker peptide at
different stoichiometric ratios r 5 [SH]/[VS]. (Error bars:
Standard error of the mean, n 5 3).
Figure 2. Elastic shear modulus (G0) of hydrogels formed
from 4-arm PEG-VS and tri-amino acid linker peptide at
different stoichiometric ratios r 5 [SH]/[VS]. (Error bars:
Standard error of the mean, n 5 3).
Figure 3. Degradation of hydrogels in PBS containing
0.1 U/mL plasmin at 378C monitored for 30 h (a) and
130 h (b). (Error bars: Standard error of the mean, n 5 3).
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the same diameter in rats, and sacriﬁced animals
after 3 week to analyze via histology the response of
the materials to its in vivo environment. Histology
demonstrated a highly materials-dependent cellular
inﬁltration and bone-healing outcome (Fig. 4).
Nondegradable CSC-type gels showed a sharp
interface between the still intact hydrogel and the sur-
rounding tissue (Fig. 4, top row; note that the mineral-
ized phase shows up in green). Apparently, the pres-
ence of 5 lg BMP-2 per implant led to bone formation
Figure 4. Histological analyses of cell inﬁltration and bone healing. Cross-sections of defects 3 weeks after gel implanta-
tion. Representative sections of implants of three animals are shown for each gel type.
Figure 5. Histological analyses of cell inﬁltration at higher magniﬁcation. Cross-sections of defects 3 weeks after gel
implantation. Representative sections of one implant are shown for each gel type. The small black and red squares in the
complete cross-sections correspond to the higher magniﬁcation shown in the middle and right columns, respectively.
(Scale bars 5 200 lm).
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around the plasmin-insensitive implants. The smooth
surface of the gel phase indicated that no cell inﬁltra-
tion took place. Therefore, the nondegradable and rel-
atively dense gel matrix acted as a physical barrier for
surrounding cells. Qualitatively, plasmin-degradable
gels showed a markedly different outcome. The tis-
sue-gel interface of most explants was not smooth but
rather irregularly shaped, showing signs of extensive
inﬁltration by host cells (Fig. 4).
As is evident at higher magniﬁcation (Fig. 5), these
irregularities were created by local, cell-mediated gel
breakdown, consistent with earlier ﬁndings.11 In some
implants, the plasmin degradation of hydrogels
enabled a more pronounced de novo bone formation
through gel remodeling, when compared with the
nondegradable control. Surprisingly, the most exten-
sive gel degradation was observed in CRC gels and
not in C2KR gels that in vitro showed the fastest deg-
radation (Fig. 3). The apparent contradiction between
in vivo and in vitro data may be attributed to the fact
that in a complex in vivo regeneration microenviron-
ment, many types of proteases can be found and
therefore, even though the peptides were designed as
plasmin substrates, other proteases such as MMPs
could be responsible for the in vivo gel degradation.
Moreover, due to the variability among the animals of
even the same gel type, which may be attributed for
example to differences in mechanical properties but
also differential BMP2-retention (previously shown to
be ca. 90% in PEG-based gels10), larger sample num-
bers and a quantiﬁcation of healing are crucial to
substantiate these data.
In an earlier study of gels composed of the same
plasmin substrate YKNRD as in the present C2KR
gels, a more extensive cell inﬁltration was observed at
3 week and the same dose of BMP-2.11 In some
regions, the entire thickness of implants was replaced
by cellular processes. This discrepancy may be
explained by the fact that the previous gels were com-
posed of a different molecular architecture (peptides
containing three cysteines crosslinked with linear
PEG-VSs) that led to a less densely crosslinked net-
work, which could have resulted in a more rapid deg-
radation of implants. Nevertheless, our experiments
revealed that minimal plasmin substrates as gel
components can be degraded via endogenous mecha-
nisms in an in vivo context, and in which this charac-
teristic can be explored to regenerate large bone
defects in a critical size defect model. Longer implan-
tation times will reveal whether these novel gels are
completely remodeled by natural mineralized tissue.
CONCLUSIONS
We show that tri-amino acid peptides bearing
lysine or arginine, ﬂanked by cysteines, can serve as
key functional components of plasmin-degradable
PEG hydrogels. Substitution of lysine or arginine
with serine residues rendered the hydrogels insensi-
tive to plasmin. Despite of the slower in vitro gel
degradation rate when compared with gels with lon-
ger, naturally derived plasmin substrates (C2KR), in
an in vivo context of bone regeneration, the maxi-
mally truncated substrates performed similarly well.
The modularity to incorporate desired biomolecules
into the present hybrid hydrogels, together with
their signiﬁcantly lower costs, promises to render
these materials attractive for clinical applications.
The authors thank Dr. Hugo G. Schmoekel for conduct-
ing the animal experiments.
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